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Background: Preoperative characterization of complex solid and cystic adnexal masses is crucial for informing
patients about possible surgical strategies. Our study aims to determine the usefulness of apparent diffusion
coefficients (ADC) for characterizing complex solid and cystic adnexal masses.
Methods: One-hundred and 91 patients underwent diffusion-weighted (DW) magnetic resonance (MR) imaging of
202 ovarian masses. The mean ADC value of the solid components was measured and assessed for each ovarian
mass. Differences in ADC between ovarian masses were tested using the Student’s t-test. The receiver operating
characteristic (ROC) was used to assess the ability of ADC to differentiate between benign and malignant complex
adnexal masses.
Results: Eighty-five patients were premenopausal, and 106 were postmenopausal. Seventy-four of the 202 ovarian
masses were benign and 128 were malignant. There was a significant difference between the mean ADC values of
benign and malignant ovarian masses (p < 0.05). However, there were no significant differences in ADC values
between fibrothecomas, Brenner tumors and malignant ovarian masses. The ROC analysis indicated that a cutoff
ADC value of 1.20 x10-3 mm2/s may be the optimal one for differentiating between benign and malignant tumors.
Conclusions: A high signal intensity within the solid component on T2WI was less frequently in benign than in
malignant adnexal masses. The combination of DW imaging with ADC value measurements and T2-weighted signal
characteristics of solid components is useful for differentiating between benign and malignant ovarian masses.
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Ovarian tumors are the leading indication for gynecologic
surgery, and the preoperative characterization of complex
solid and cystic adnexal masses is crucial for informing
patients about possible surgical strategies. Recently, in
order to improve quality of life, laparoscopic surgery has
been increasingly used for the treatment of ovarian
tumors that are believed to be benign. For malignant ovar-
ian lesions, there is no evidence that laparoscopy for the* Correspondence: wenhualimyj@sohu.com
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reproduction in any medium, provided the ormanagement of early stage ovarian tumors may improve
the quality of life [1-3].
Ultrasonography (US) is the first-line imaging modality
for adnexal lesions and is a particularly useful preopera-
tive test for the characterization of noncomplex masses.
Magnetic resonance imaging (MRI) may be of great help
in identifying malignant lesions before surgery, particu-
larly when US findings are suboptimal or indeterminate
[4-10]. MRI can reveal morphologic characteristics such
as papillary projections, nodularity, septa, solid portions
and signal intensity on T1- and T2-weighted images, but
none of these criteria reliably distinguish between benign
and malignant tumors. The use of magnetic resonance
(MR) diffusion-weighted imaging (DWI) may improveLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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weighted imaging is sensitive to changes in the microdif-
fusion of water into both intracellular and extracellular
spaces. Differences in the apparent diffusion coefficient
(ADC) of benign and malignant complex adnexal masses
have been reported [11-13]. Kayayama et al. [11] and
Fujii et al. [14] assessed the feasibility of DWI for the
differentiation of benign and malignant ovarian lesions.
They concluded that the ADC values of cystic and solid
components were not useful for differentiating between
lesions. However, their data included endometrial cysts,
mature cystic teratomas, and fibromas and fibrotheco-
mas, in which hemorrhagic contents, sebaceous materi-
als and fibrous tissue may cause an increase or a
reduction in signal on DWI.
The purpose of this study was to clarify the relation-
ship between the ADC values of the solid components
of benign and malignant ovarian lesions, and to evaluate
the supplementary use of ADC values of the solid com-
ponents for differentiating between benign and malig-
nant lesions.
Methods
Patients
Our institutional review board approved the study and
waived the requirement to obtain written informed con-
sent. A total of 601 female patients evaluated for ovarian
tumors between January 2005 and December 2011 were
enrolled. A retrospective review of MRI data was under-
taken. The MRI studies met the following inclusion cri-
teria for the study: (1) MRI was performed using a 1.5T
magnet, and (2) both conventional MRI with DWI and
dynamic contrasted-enhancement MRI were performed.
In addition, the diagnosis was confirmed by surgery and
pathological examination. Of the 601 patients, 383 were
excluded due to the presence of endometriomas (n = 73),
mature cystic or immature teratomas (n = 39), and purely
cystic ovarian lesions (including simple cysts and purely
cystic adenomas) with thin and regular walls and/or septa
(n = 232). A further 27 were excluded due to failed fat
suppression or artifacts. The remaining 191 patients with
202 complex adnexal masses were included in the study.
MR protocol
All subjects underwent MRI with a 1.5T MR unit
(Twinspeed, GE Medical Systems, Milwaukee, WI,
USA). The imaging protocol involved axial non-contrast
T1-weighted (TR/TE, 400-600/10-14 ms) and axial
T2-weighted (TR/TE, 4,000-6,000/100-120 ms) imaging
performed with a chemical shift-selective fat saturation
pulse using the following parameters: slice thickness, 5
mm; gap, 1 mm; field of view (FOV), 32 to 42 cm; matrix,
256 × 256; and excitation, 2. Sagittal T1-weighted and
T2-weighted (TR/TE, 3,000-6,000/100-110 ms) fast spin-echo imaging without chemical shift-selective fat satur-
ation pulse was also performed, as well as post-contrast
enhanced axial and sagittal T1-weighted imaging using
parameters as described above, apart from a slice thick-
ness of 5 mm. Diffusion-weighted MRI was acquired in
the axial plane prior to administration of contrast
medium using a single-shot echo-planar imaging se-
quence (TR/TE effective range, 8,000-10,000/70-100;
slice thickness/intersection gap, 5/1 mm; FOV, 32 to 42
cm; matrix, 128 × 128; excitation, 2. A b-value of 0 and
of 1,000 s/mm2 was also applied in three orthogonal
(Z, Y, and X) directions.
MRI analysis
Conventional MRI and DWI imaging data were analyzed
on an Advantage Windows workstation 4.2 (GE Health-
care, Milwaukee, WI, USA) by two radiologists (with
15- and 10- year experience in pelvic MRI, respectively),
in consensus, having carefully reviewed all images. The
solid component, according to a previously established
classification by Timmerman et al. [7] included thick-
ened septa, vegetation (papillary projection) and solid
portions that showed enhancement post-injection. The
cystic component was defined as tissue with homoge-
neous long T1 and T2 characteristics or different signal
intensities on T1- or T2-weighted MR images, and
showed no enhancement post-injection. The signal in-
tensity of solid components on T2-weighted MR images
was defined as low or intermediate (equal to or greater)
compared to that of the outer myometrium. The signal
intensity of the cystic and solid components on DWI at b =
1,000 s/mm2 was classified as intermediate or low com-
pared to that of serous fluid (urine or cerebrospinal fluid).
Data calculation and analysis
The solid components of the lesions were identified on
T2-weighted and post-contrast T1-weighted images, and
were matched on ADC maps. The ADC values of the solid
components of each tumor were measured on DW images
by a radiologist using an Advantage Windows workstation
4.2 (GE Healthcare), using the manufacturer’s software
(FuncTool; GE, Medical Systems, Milwaukee, WI, USA). In
order to minimize variability, the largest possible regions
of interest (ROIs), which varied from 15 to 150 mm2,
were manually placed in the solid parts of the tumor.
When the lesion exhibited irregular or heterogeneous
solid components, numerous vegetations or thickened ir-
regular septa, between two and five ROIs were drawn
within the targeted components and the mean ADC
value was used in the analysis.
Statistical analysis
Surgical pathological findings served as the reference
standard for assessment of ovarian tumors. All analyses
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(SPSS, Chicago, IL, USA). Differences in mean tumor
ADC values between benign and malignant groups were
evaluated using Student’s t-test. A P-value < 0.05 was
considered statistically significant. Receiver operating
characteristic (ROC) curve analysis was performed in
order to assess the diagnostic performance of the mean
ADC values in terms of characterization of benign and
malignant ovarian tumors.
Results
Clinical demographics
The surgical pathological types of 202 complex adnexal
masses in 191 patients can be seen in Table 1. The mean
patient age was 56.52 ±15.31 (mean±SD; range, 12 to
85) years. Eighty-five women (44.5%) were premenopau-
sal and 106 (55.5%) were postmenopausal. Seventy-four
(36.6%) of the 202 ovarian masses were benign, and 128
(63.4%) were malignant.
MRI findings
A high signal intensity within the solid component on
T2-weighted MR images was observed less frequently in
benign (39/74) than in malignant (108/128) adnexal
masses (P < 0.01). The solid portion of 74 benign
complex adnexal lesions contained homogeneous or
heterogeneous low signal intensity on T2-weighted
images in 100% of cystadenofibromas (Figure 1), 83.3%
of fibrothecomas (Figure 2), 80.0% of Brenner tumors,
23.5% of mucinous cystadenomas, and 21.4% of serous
cystadenomas (Figure 3). Among 128 malignant complex
adnexal masses, only 20 (15.6%) displayed a low signalTable 1 Histological types and apparent diffusion coefficient
Type of ovarian mass Lesions, number High SI on T2-W
Benign ovarian lesions 74 39 (52.7)
Serous cystadenoma 28 22 (78.6)
Mucinous cystadenoma 17 13 (76.5)
Fibrothecoma 18 3 (16.7)
Cystadenofibroma 6 0 (0)
Brenner tumor 5 1 (20)
Malignant ovarian lesions 128 108 (84.4)
Serous cystadenocarcinoma 35 26 (74.3)
Mucinous cystadenocarcinoma 27 20 (74.1)
Serous borderline tumor 12 10 (83.3)
Mucinous borderline tumor 9 8 (88.9)
Clear cell adenocarcinoma 8 8 (100)
Endometrioid adenocarconoma 6 6 (100)
Granulosa cell tumor 7 6 (85.7)
Undifferentiated adenocarcinoma 5 5 (100)
Metastatic tumors 19 19 (100)
Numbers in parentheses are percentages; ADC values, (mean ± SD × 10-3mm2/s); T2intensity of their solid components on T2-weighted
images (Figure 4). On DWI, a high signal intensity at
b = 1,000 s/mm2 within the solid component was
observed less frequently in benign (71.6%) than in malig-
nant (100%) adnexal masses (P < 0.05). Our results dem-
onstrate that the following factors can be considered
predictive of malignancy: the presence of a solid compo-
nent with high or low signal intensity on T2-weighted
images and high signal intensity on DWI with low ADC
values (less than 1.20 × 10-3 mm2/s) at b = 1,000 s/mm2.
On the other hand, the following factors can be consid-
ered predictive of a benign mass: the presence of a solid
component with high or low signal intensity on T2-weighted
images and high signal intensity on DW images with high
ADC values (greater than 1.20 × 10-3 mm2/s), or low signal
intensity on T2-weighted images and DW images with lower
ADC values at b = 1,000 s/mm2.
ADC analysis
The mean ADC values of the tumor solid components
were determined for each group. There was much over-
lap between the range of values observed for benign and
for malignant tumors. However the mean ADC value for
benign tumors was 1.22 ± 0.46 × 10-3 mm2/s, and for
malignant tumors 0.91 ± 0.20 × 10-3 mm2/s, which was
a significant difference (P < 0.05). This result suggests
that an ADC value ≥ 1.20 × 10-3 mm2/s may be the opti-
mal cutoff for differentiating between benign and malig-
nant tumors, with a sensitivity of 66.7%, a specificity of
90.9%, a positive predictive value (PPV) of 81.4%, a nega-
tive predictive value (NPV) of 82.1%, and an area under
the curve (AUC) of 0.72. In our study, the mean ADC(ADC) values of 202 ovarian masses
I High SI on DWI Range of ADC values Mean ADC values
53 (71.6) 0.12, 1.81 1.22 ± 0.46
28 (100) 1.23, 1.81 1.52 ± 0.19
17 (100) 1.12, 1.79 1.48 ± 0.20
3 (16.7) 0.40, 1.58 0.82 ± 0.44
0 (0) 0.12, 0.94 0.52 ± 0.26
5 (100) 0.88, 1.44 1.06 ± 0.23
128 (100) 0.56, 1.45 0.91 ± 0.20
35 (100) 0.66, 1.35 0.97 ± 0.20
20 (100) 0.65, 1.31 0.89 ± 0.19
10 (100) 0.78, 1.45 1.05 ± 0.19
9 (100) 0.75, 1.36 0.99 ± 0.17
8 (100) 0.69, 1.01 0.82 ± 0.13
6 (100) 0.71, 1.06 0.93 ± 0.11
6 (100) 0.79, 1.33 0.98 ± 0.18
5 (100) 0.64, 1.19 0.83 ± 0.23
19 (100) 0.56, 1.09 0.86 ± 0.15
-WI, T2-weighted image; SI, signal intensity; DWI, diffusion-weighted imaging.
Figure 1 A 67-year-old woman with an ovarian
cystadenofibroma. (A) Axial T1-weighted image shows a right
ovarian mass with a hypointensity. (B) Axial T2-weighted image
reveals that the solid part of the mass is hypointense (arrow) and
the cystic component is hyperintense. (C) Axial diffusion-weighted
imaging (DWI) reveals that the solid part of the mass has a very
low signal intensity (circle 1, apparent diffusion coefficient
(ADC) = 0.592 × 10-3 mm2/s).
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comas and Brenner tumors. There was no statistically
significant difference between values for fibrothecomas,
Brenner tumors and malignant tumors (P > 0.05), but
there was a significant difference between values
observed for cystadenofibromas and for malignant
tumors (P = 0.002). When cystadenofibromas, fibrothe-
comas and Brenner tumors were excluded from the ana-
lysis, the sensitivity, specificity, PPV, NPV, and AUC for
the optimal cutoff ADC value of 1.20 × 10-3 mm2/s for
differentiating between benign and malignant tumors,
were 97.7%, 90.1%, 86.6%, 99.1%, and 0.96, respectively
(Figure 5).
Discussion
Our findings demonstrate that the presence of high sig-
nal intensity in solid components of ovarian lesions on
DW and T2-weighted imaging combined with low ADC
values can be used to distinguish malignant from benign
ovarian lesions. The results also suggest a potential role
for DW imaging with quantitative analysis of ADC
values in improving the diagnostic performance of ovar-
ian MRI and yielding functional measures of the tumor
microenvironment.
In the present study, ADC values are largely propor-
tional to the ratio of extracellular and intracellular com-
ponents, cell density, intracellular organelles, matrix
fibers, and soluble macromolecules. Although some
overlap in ADC values was observed between the benign
and malignant groups, the mean ADC value of the 128
malignant ovarian tumors was significantly lower than
that of the 74 benign ovarian tumors (P < 0.05). Our
results suggest that an ADC value ≥ 1.20 × 10-3 mm2/s
may be the optimal cutoff for differentiating between
benign and malignant tumors. Furthermore, a sensitivity
of 66.7%, a specificity of 90.9%, a PPV 81.4%, an NPV
of 82.1%, and an AUC of 0.72, was observed with this
ADC cutoff value. This result is consistent with previ-
ous reports [10,12,15,16]. In a study by Fujii et al.
[14], the authors evaluated the contribution of DWI in
combination with quantitative ADC analysis to the
characterization of 123 ovarian lesions, which included
42 malignant and 81 benign lesions (including 7 fibro-
mas, 18 mature cystic teratomas and 24 endometrio-
mas). The results suggest that DW imaging of ovarian
lesions and ADC values of the solid component are
not useful for differentiating between benign and ma-
lignant ovarian lesions. This apparent discrepancy is
probably due to the pathologic architectures of benign
tumors. In our series, 83.3% (15/18) of fibrothecomas,
100% (6/6) of cystadenofibromas and 80% (4/5) of
Brenner tumors demonstrated low signal intensity in
the solid components on DWI and low ADC values,
due to the presence of abundant collagen-producing
Figure 2 A 27-year-old woman with an ovarian fibrothecoma. (A) An axial T1-weighted image shows a right ovarian mass with
hypointensity. (B) Axial T2-weighted image shows a solid heterogeneous signal mass; the area containing abundant fibrous tissue has marked
low signal intensity (arrow) and the area containing an abundant thecoma component has intermediate signal intensity (arrowhead). (C) On axial
diffusion-weighted imaging (DWI), the apparent diffusion coefficient (ADC) value of the fibrous tissue area is very low (circle 1, ADC = 1.05 × 10-3
mm2/s) and that of the thecoma component is very high (circle 2, ADC = 1.45 × 10- 3 mm2/s). (D) Sagittal T2-weighted image demonstrates
endometrial thickening.
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within the extracellular matrix, which can restrict the
Brownian motion of water molecules. Previous studies
have also reported that endometriomas and matureFigure 3 A 28-year-young woman with bilateral benign serous ovaria
tumor with hypointensity. (B) Axial T2-weighted image shows a complex a
components as vegetations with intermediate signal intensity (arrow). (C) A
shows the solid component as hyperintense with a high apparent diffusion
cystic component with an even higher value (circle 2, ADC = 2.59 × 10- 3 m
slight enhancement of the solid component (arrow).teratomas exhibit low ADC values [11]. This could ex-
plain the observed absence of a difference between the
mean ADC values of benign and malignant ovarian
lesions in the study by Fujii et al. [14].n cystadenomas. (A) An axial T1-weighted image shows a pelvic
dnexal tumor with solid and cystic components, and solid
xial diffusion-weighted imaging (DWI) obtained at b =1,000 s/mm2
coefficient (ADC) value (circle 1, ADC = 1.26 × 10-3 mm2/s), and the
m2/s). (D) Axial contrast-enhanced T1-weighted image demonstrates
Figure 4 A 63-year-old woman with a left ovarian cystadenocarcinoma. (A) An axial T1-weighted image shows a left pelvic mass with
isointensity. (B) Axial T2-weighted image reveals that the mass is a solid tumor with low signal intensity. (C) Axial diffusion-weighted imaging
(DWI) obtained at b = 1,000 s/mm2 reveals the solid tumor as hyperintense with a lower apparent diffusion coefficient (ADC) value (circle 1,
ADC = 0.769 × 10-3 mm2/s). (D) Axial contrast-enhanced T1-weighted image demonstrates marked enhancement of the solid part.
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tensity within solid components with low ADC values
on DWI is a useful criterion for predicting malignancy.
In our study, on T2-weighted images solid components
of malignant tumors had high signal intensity in 84.4%
and low signal intensity in 15.6%. On the other hand,
100% of solid components in malignant lesions had high
signal intensity on DW images with low ADC values.
This finding, that of low signal intensity on T2-weightedFigure 5 Comparative diagnostic values of quantitative apparent diff
between benign and malignant ovarian tumors. When an absolute AD
receiver operating characteristic (ROC) analysis, the area under the curve (A
and Brenner tumors are excluded, the ROC AUC is the greatest (0.96), and
benign and malignant ovarian masses (b).images and high signal intensity on DWI in solid compo-
nents, may result from a reduction in both the extracellu-
lar matrix and the diffusion space of water protons in the
extracellular and intracellular dimensions due to an
increased nuclear to cytoplasmic ratio and hypercellular-
ity. However, the low signal intensity on T2-weighted
images and DWI in benign ovarian tumors such as
fibrothecomas, cystadenofibromas and Brenner tumors,
may be due to the high density of fibers, the low cellularity,usion coefficient (ADC) value parameters for discriminating
C value less than 1.20 × 10-3 mm2/s is predictive of malignancy, on
UC) (a) is small (0.72), and when fibrothecomas, cystadenofibromas
thus it is probably the most effective factor for discriminating between
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cellular spaces [13-20]. Our study suggests that low signal
intensity on T2-weighted images and DWI with low ADC
values within a solid component is an effective criterion
for predicting the presence of benign disease.
There were several limitations to our study. First, the
exclusion of endometriomas and mature cystic terato-
mas and pure cystic adenomas may have induced a
selection bias. As recommended by Takeuchi et al.
[16], the DWI findings of endometriomas and mature
cystic teratomas are problematic, and most cases can
be accurately diagnosed on conventional MRI. Secondly,
drawing the ROI on DW images while viewing T2-weighted
or contrasted T-weighted images may have resulted in an
information bias, as DWI usually has poor spatial reso-
lution. A better approach would be to fuse DW images at
b = 1,000 × 10-3 mm2/s onto structural images in order to
accurately position the ROI of solid components that show
an abnormal signal on DW images. Thirdly, the reported
ADC threshold value needs to be validated in a larger
group of patients, as many factors can affect the ADC
value, including magnetic susceptibility, spatial resolution,
signal to noise ratio, and the pathophysiological characteris-
tics of the ovarian lesion.Conclusion
DWI appears to be a useful method for differentiating
between benign epithelial ovarian tumors with solid
components and malignant ovarian tumors, and is asso-
ciated with high sensitivity and specificity. The solid
component within the complex adnexal mass that exhi-
bits low signal intensity on T2-weighted images and DW
images is invariably benign. In addition, a notable advan-
tage of DWI is that it avoids further impairment of renal
function, as the use of contrast medium is not necessary.
For patients with renal failure, this would prevent the
development of fibrosis.Competing interests
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